These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 312352

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Modulation of thymus-leukemia antigens on mouse leukemia cells induced by IgG, but not IgM, antibody.
    Stackpole CW.
    J Natl Cancer Inst; 1980 Apr; 64(4):917-23. PubMed ID: 6929003
    [Abstract] [Full Text] [Related]

  • 3. Antigenic modulation in vitro. III. Failure to modulate H-2 antigens on several mouse tumors.
    Richards JM, Jacobson JB, Stackpole CW.
    J Natl Cancer Inst; 1979 Apr; 62(4):825-32. PubMed ID: 311870
    [Abstract] [Full Text] [Related]

  • 4. Detection of a TL(+) murine leukemia cell line that resists the cytotoxic effects of guinea pig complement and specific antiserum.
    Yu A, Liang W, Cohen EP.
    J Natl Cancer Inst; 1975 Aug; 55(2):299-308. PubMed ID: 51085
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antigenic modulation in vitro. I. Fate of thymus-leukemia (TL) antigen-antibody complexes following modulation of TL antigenicity from the surfaces of mouse leukemia cells and thymocytes.
    Stackpole CW, Jacobson JB, Lardis MP.
    J Exp Med; 1974 Oct 01; 140(4):939-53. PubMed ID: 4610077
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antigenic modulation in vitro. II. Modulation of thymus-leukemia (TL) antigenicity requires complement component C3.
    Stackpole CW, Jocobson JB, Galuska S.
    J Immunol; 1978 Jan 01; 120(1):188-97. PubMed ID: 627716
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Monoclonal anti-TL antibody recognizing a TL.2-like antigen.
    Kuśnierczyk P, Szkudlarek J, Steuden I.
    Arch Immunol Ther Exp (Warsz); 1984 Jan 01; 32(6):637-40. PubMed ID: 6536234
    [Abstract] [Full Text] [Related]

  • 13. Immunoregulatory changes induced by total lymphoid irradiation (TLI). I. Appearance of a population of cells bearing the thymus leukemia (TL) surface antigen in the lymph nodes and spleen.
    King DP, Strober S, Kaplan HS.
    J Immunol; 1981 Sep 01; 127(3):1085-9. PubMed ID: 6973579
    [Abstract] [Full Text] [Related]

  • 14. Demonstration of thymus-leukemia (TL) antigens on mitochondria of lymphoid cells by immunoelectron microscopy.
    Jeng MW, Finegold MJ, Basch RS, Lamm ME.
    Lab Invest; 1978 Jan 01; 38(1):41-4. PubMed ID: 74453
    [Abstract] [Full Text] [Related]

  • 15. Independent control of the expression of several membrane-associated antigens of murine leukemia cells: metabolism and response to specific antiserum.
    Cohen EP, Liang W.
    Prog Clin Biol Res; 1976 Jan 01; 9():89-99. PubMed ID: 1030806
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
    Yan J, Vetvicka V, Xia Y, Coxon A, Carroll MC, Mayadas TN, Ross GD.
    J Immunol; 1999 Sep 15; 163(6):3045-52. PubMed ID: 10477568
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.